The EP(Pharma) Division deals with export promotion of Pharmaceutical products and the administrative matters pertaining to the Export Promotion Council for Pharma viz. Pharmaceutical Export Promotion Council of India (Pharmexcil).
Export Products (Pharmaceuticals)
Functions of the Division
Officers in the Division
Ms. Indu C. Nair | Joint Secretary
- Room No. 444, Vanijya Bhawan
- Tel.: 23039560
- Email: indu.nair@gov.in
Shri Y.P. Dhewal | Director
- Room No. 219, Udyog Bhawan
- Tel.: 23063365
- Email: direurope-doc@gov.in
Shri Anurag Goel | Under Secretary
- Room No. 477, Udyog Bhawan
- Tel.:23063428
- Email: anurag.goel@nic.in
Bilateral Trade Statistics
Category wise exports during last three years
Product Category
|
2019-20
|
2020-21
|
2021-22
|
% Growth
|
Drugs formulations & Biologicals
|
15948.83
|
19042.17
|
19021.05
|
-0.11
|
Bulk Drugs & Drug Intermediates
|
3867.77
|
4429.70
|
4472.05
|
0.96
|
Ayush & Herbals
|
428.07
|
539.88
|
612.83
|
13.51
|
Surgicals
|
458.79
|
432.29
|
512.86
|
18.64
|
Grand Total
|
20703.46
|
24444.03
|
24618.78
|
0.71
|
(Source: DGCIS)
Region wise exports during last three years
Region
|
2019-20
|
2020-21
|
2021-22
|
% Growth
|
NAFTA
|
7258.60
|
8392.84
|
7820.77
|
-6.82
|
EUROPE
|
3574.36
|
4234.59
|
4426.61
|
4.53
|
AFRICA
|
3213.86
|
3917.90
|
3856.27
|
-1.57
|
LAC
|
1227.99
|
1447.66
|
1710.25
|
18.14
|
ASEAN
|
1292.65
|
1462.00
|
1761.01
|
20.45
|
WANA
|
1034.02
|
1320.44
|
1335.73
|
1.16
|
SOUTH ASIA
|
1167.69
|
1238.02
|
1300.48
|
5.05
|
CIS
|
905.27
|
1177.96
|
1097.89
|
-6.80
|
NEA
|
684.07
|
823.98
|
803.03
|
-2.54
|
OCEANIA
|
344.94
|
428.23
|
466.21
|
8.87
|
UNSPECIFIED
|
0.02
|
0.41
|
40.52
|
9782.93
|
Grand Total
|
2070
|
2444
|
2461
|
0.71
|
(Source: DGCIS)
(Source: DGCIS)
Top 25 export destinations of India’s Pharmaceuticals products
Rank
|
Country
|
2019-20
|
2020-21
|
2021-22
|
% Growth
|
1
|
U S A
|
6749.60
|
7718.80
|
7101.60
|
-8.00
|
2
|
U K
|
557.89
|
716.52
|
704.51
|
-1.68
|
3
|
SOUTH AFRICA
|
612.01
|
833.53
|
612.30
|
-26.54
|
4
|
RUSSIA
|
552.41
|
590.69
|
597.81
|
1.21
|
5
|
NIGERIA
|
443.09
|
573.17
|
588.59
|
2.69
|
6
|
BRAZIL
|
473.10
|
525.28
|
580.78
|
10.57
|
7
|
GERMANY
|
504.17
|
575.47
|
528.30
|
-8.20
|
8
|
FRANCE
|
319.50
|
412.81
|
512.20
|
24.08
|
9
|
NETHERLAND
|
321.05
|
375.18
|
460.08
|
22.63
|
10
|
BELGIUM
|
297.18
|
370.19
|
449.77
|
21.50
|
11
|
CANADA
|
334.54
|
441.77
|
418.57
|
-5.25
|
12
|
AUSTRALIA
|
274.10
|
346.73
|
386.90
|
11.58
|
13
|
CHINA P RP
|
287.97
|
371.31
|
343.76
|
-7.42
|
14
|
PHILIPPINES
|
263.99
|
284.40
|
342.25
|
20.34
|
15
|
KENYA
|
275.55
|
282.79
|
341.37
|
20.72
|
16
|
U ARAB EMTS
|
203.13
|
321.64
|
333.77
|
3.77
|
17
|
MYANMAR
|
224.75
|
234.57
|
329.95
|
40.66
|
18
|
NEPAL
|
247.26
|
231.32
|
320.12
|
38.39
|
19
|
BANGLADESH
|
250.95
|
261.43
|
309.12
|
18.24
|
20
|
MEXICO
|
159.96
|
212.43
|
287.61
|
35.39
|
21
|
TURKEY
|
216.57
|
295.24
|
282.48
|
-4.32
|
22
|
VIETNAM
|
223.76
|
243.90
|
269.05
|
10.31
|
23
|
TANZANIA
|
218.35
|
262.62
|
260.00
|
-1.00
|
24
|
INDONESIA
|
107.16
|
158.51
|
253.32
|
59.82
|
25
|
PAKISTAN
|
124.71
|
152.32
|
243.36
|
59.77
|
Total for above 25 Countries
|
14242.73
|
16792.59
|
16857.57
|
0.39
|
|
Other countries
|
6460.74
|
7651.44
|
7761.20
|
1.43
|
|
Total Export
|
20703.47
|
24444.03
|
24618.77
|
0.71
|
(Source: DGCIS
(Source: DGCIS)
Trade promotion activities
Events/Buyer-Seller Meets organized/participated by Pharmexcil under MAI Scheme
FY 2020-21
S.No.
|
Name of the Event
|
Event Dates
|
1
|
BSM in Africa Region – Nigeria, Ehtiopia, Tanzania,
Uganda, Kenya (Virtual)
|
15-19 February, 2021
|
2
|
BSM in LAC Region – Colombia, Mexico, Peru,
Bolivia, Chile, Guatemala, El Salvador, Honduras
(Virtual)
|
23-27 February, 2021
|
3
|
BSM in ASEAN Region – Vietnam, Indonesia,
Phillippines, Myanmar, Thailand, Cambodia (Virtual)
|
15-22 March, 2021
|
4
|
BSM in CIS Region – Russia, Uzbekistan,
Turkmenistan, Ukraine, Kazakhstan (Virtual)
|
22-26 March, 2021
|
FY 2021-2022
S.No.
|
Name of the Event
|
Event Dates
|
1
|
Pharmaconex, Cairo, Egypt (Physical participation)
|
03-05 October, 2021
|
2
|
BSM in INDO – OCEANIA CONNECT (Virtual)
Pharma Webinar & B2B Meetings with Australia,
New Zealand, Fiji
|
16-19 November, 2021
|
3
|
BSM in INDO GCC CONNECT 2021 (Virtual)
pharma webinar & B2B Meetings with UAE, Saudi
Arabia, Bahrain, Qatar and Oman
|
06-13 December, 2021
|
4
|
BSMs in India-North East Asia Virtual Pharma
Connect China, Japan
|
17-21 December, 2021
|
5
|
Arab Health 2022 (Physical participation)
|
24-27 January, 2022
|
6
|
BSMs in CIS REGION – Uzbekistan & Kazakhstan
(Physical participation)
|
23-30 March, 2022
|
Mandatory disclosures under RTI Act
Appellate Authority
Ms. Indu C. Nair | Joint Secretary
- Department of Commerce
- Room No : 444
- Tel : 23039560
- Email: indu.nairat]gov[dot]in
CPIO
Shri Y.P. Dhewal | Director
- Department of Commerce
- Room No. 219, Udyog Bhawan, New Delhi-110011
- Tel.: 23063365
- Email: direurope-doc[at]gov[dot]in
EPCs like Pharmexcil are not covered under the RTI Act provisions. However, for any information directly pertaining to the Council, an applicant can approach the council directly and it generally provides information which are not in conflict with commercial activities of its members. GoI can provide information as per record available pertaining to aspects related to the functioning of the Division and related aspects.
Pharmexcil is not under the administrative control of the government since it is an industry body and enjoys autonomy in administrative matters for creation of posts, service matters etc.
However, the function of such EPCs are governed by para 2.55 of FTP 2015-20.